These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Chemoprevention in colorectal neoplasias: what is practical and feasible? Ricciardiello L; Roda E; Bazzoli F Dig Dis; 2002; 20(1):70-2. PubMed ID: 12145422 [TBL] [Abstract][Full Text] [Related]
26. [Gastroduodenal tolerance of celecoxib (celebrex) in patients with osteoarthrosis: an endoscopic evaluation]. Karateev AE Ter Arkh; 2001; 73(5):63-4. PubMed ID: 11517755 [No Abstract] [Full Text] [Related]
27. Pain management in patients with osteoarthritis. Finucane TE JAMA; 2003 Jul; 290(1):36; author reply 36. PubMed ID: 12837705 [No Abstract] [Full Text] [Related]
28. [Specific inhibitors of cyclooxygenase-2 (COX-2): current knowledge and perspectives]. Rioda WT; Nervetti A Acta Biomed Ateneo Parmense; 2001; 72(3-4):55-64. PubMed ID: 11889908 [TBL] [Abstract][Full Text] [Related]
29. Celecoxib for arthritis. Med Lett Drugs Ther; 1999 Jan; 41(1045):11-2. PubMed ID: 9949762 [No Abstract] [Full Text] [Related]
30. [Pharma-clinics. The drug of the month. Celecoxib (Celebrex)]. Scheen AJ Rev Med Liege; 2001 Jan; 56(1):53-5. PubMed ID: 11256140 [TBL] [Abstract][Full Text] [Related]
31. Drug safety. FDA panel urges caution on many anti-inflammatory drugs. Couzin J Science; 2005 Feb; 307(5713):1183-5. PubMed ID: 15731414 [No Abstract] [Full Text] [Related]
32. [Non-steroidal anti-inflammatory agents and prevention of colorectal adenomas and carcinomas]. Raskov HH Ugeskr Laeger; 2006 Jan; 168(4):359-62. PubMed ID: 16436235 [No Abstract] [Full Text] [Related]
33. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex). Wynn RL Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547 [No Abstract] [Full Text] [Related]
35. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention. Vanchieri C J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872 [No Abstract] [Full Text] [Related]
36. Celecoxib: a COX-2 inhibitor. Andrews SA; Wallace CK; Davis RL Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389 [No Abstract] [Full Text] [Related]
37. Celecoxib in a 12-year-old boy with familial adenomatous polyposis. Pérez-Segura P; Bodas A; Sereno M; Martínez-Amores B; Olivera H; Díaz S; López-Asenjo JA; Puente J; Maluenda C; Díaz-Rubio E Int J Clin Pharmacol Ther; 2010 Mar; 48(3):230-2. PubMed ID: 20197018 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis. Suárez-Otero R; Robles-San Román M; Jaimes-Hernández J; Oropeza-De La Madrid E; Medina-Peñaloza RM; Rosas-Ramos R; Castañeda-Hernández G Proc West Pharmacol Soc; 2002; 45():26-8. PubMed ID: 12434517 [No Abstract] [Full Text] [Related]
39. The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion. Reuben SS; Ekman EF J Bone Joint Surg Am; 2005 Mar; 87(3):536-42. PubMed ID: 15741619 [TBL] [Abstract][Full Text] [Related]
40. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer. Liao Z; Milas L; Komaki R; Stevens C; Cox JD Am J Clin Oncol; 2003 Aug; 26(4):S85-91. PubMed ID: 12902863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]